A phase 2 study of combination therapy with gemcitabine and candesartan in patients with advanced or recurrent pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Dec 2015
At a glance
- Drugs Candesartan cilexetil (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms GECA-2
- 10 Nov 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 02 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 11 May 2011 New trial record